Simon Plyte
Chief Scientific Officer at BIOMUNEX PHARMACEUTICALS | Paris, Île-de-France, France
Simon Plyte’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Simon Plyte serves as Chief Scientific Officer at BIOMUNEX Pharmaceuticals, directing the discovery and development of targeted immunotherapies for oncology indications. He focuses on advancing the company’s proprietary BiXAb® technology to engineer next-generation bi- and multispecific antibodies aimed at extending patient survival. Plyte is an alum of the University of Portsmouth and operates out of the firm’s Paris, Île-de-France location.
BEST APPROACH TO REACH Simon Plyte
Contact him through personal email with a concise proposal detailing how your solution accelerates BIOMUNEX’s BiXAb® bispecific antibody pipeline, leveraging the high confidence score to ensure reliable delivery and engagement.
Chief Scientific Officer at BIOMUNEX PHARMACEUTICALS in October 2021 - Present
Vice President Immune Oncology at Merus in October 2018 - September 2021
Senior Director, Immune Oncology at Molecular Partners AG in January 2018 - September 2018
Director, Immune Modulation II at Boehringer Ingelheim in April 2015 - December 2017
Director, New Biological Entities II at Boehringer Ingelheim in October 2013 - April 2015
Director, Biology at Congenia Srl in May 2006 - October 2013
Project leader at Nerviano Medical Sciences in May 2004 - May 2006
Laboratory Head, Project Leader at Pharmacia in January 1999 - May 2006
University of Portsmouth, PhD, August 1986 to August 1990
University of Greenwich, BsC, August 1982 to August 1986
BIOMUNEX Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of breakthrough immunotherapies using its Unique BiXAb® technology to create next generation bi- and multi-specific antibodies. Our disruptive biological approaches target a number of cancer types, in particular where there are unmet medical needs. We are committed to provide oncologists and patients with immunotherapies that are novel, efficacious and prolong life expectancy.
Discover more about BIOMUNEX PHARMACEUTICALS
President and Founder at BIOMUNEX PHARMACEUTICALS
Manage the company
Establish partnerships
Define strategy & lead operations
Associated Director R&D, Therapeutic Antibody development
Associate Director R&D at BIOMUNEX PHARMACEUTICALS
(Jan 2025 – Present)
Etudiante en 4e année à l'ESPCI Paris PSL - Master de spécialisation PSL x Sorbonne
Recherche sur les anticorps bispécifiques pour l'immunothérapie contre les cancers.
General Counsel
General Counsel at IPCURE
(Dec 2024 – Present)
Senior Scientist at Biomunex
Development of new drug candidates
Ingénieure chez Biomunex
Ingénieure at BIOMUNEX PHARMACEUTICALS
(Jan 2023 – Present)
What is Simon Plyte email address?
Email Simon Plyte at [email protected], [email protected] and [email protected]. This email is the most updated Simon Plyte's email found in 2026.
What is Simon Plyte phone number?
Simon Plyte phone number is +31615680399.
How to contact Simon Plyte?
To contact Simon Plyte send an email to [email protected], [email protected] or [email protected]. If you want to call Simon Plyte try calling on +31615680399. (updated on July 2026)
What company does Simon Plyte work for?
Simon Plyte works for BIOMUNEX PHARMACEUTICALS.
What is Simon Plyte's role at BIOMUNEX PHARMACEUTICALS?
Simon Plyte is Chief Scientific Officer
What industry does Simon Plyte work in?
Simon Plyte works in the Pharmaceuticals industry.
